Polycystic kidney disease
MONDO:0020642A usually autosomal dominant and less frequently autosomal recessive genetic disorder characterized by the presence of numerous cysts in the kidneys leading to end-stage renal failure. The autosomal dominant trait is associated with abnormalities on the short arm of chromosome 16. Symptoms in patients with the autosomal dominant trait usually appear at middle age and include abdominal pain, hematuria, and high blood pressure. Patients may develop brain aneurysms and liver cysts. Patients with the autosomal recessive trait present with progressive renal failure early in life and symptoms resulting from hepatic fibrosis. The autosomal recessive trait is associated with abnormalities of chromosome 6. Polycystic kidney disease may also result as a side effect in patients on renal dialysis.
Also known as: PKD - polycystic kidney disease, fibrocystic renal disease, polycystic kidney disease
66 clinical trials for this condition and its sub-types, 13 tagged with Polycystic kidney disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Polycystic kidney disease
-
7 sub-types
- Polycystic kidney disease 1 1 trial
- ALG9-associated autosomal dominant polycystic kidney disease 0 trials
- Polycystic kidney disease 2 0 trials
- Polycystic kidney disease 3 with or without polycystic liver disease 0 trials
- Polycystic kidney disease 6 with or without polycystic liver disease 0 trials
- Polycystic kidney disease 7 0 trials
- Polycystic kidney disease 8 0 trials
-
2 sub-types
- Polycystic kidney disease 4 0 trials
- Polycystic kidney disease 5 0 trials
-
Hope for kids with rare kidney disease: drug trial aims to slow damage
Disease control Recruiting nowThis trial tests the safety of tolvaptan, a drug that helps the body remove extra water, in 20 children aged 28 days to 18 years with autosomal recessive polycystic kidney disease (ARPKD). The goal is to see if the drug can slow kidney function decline and reduce the need for dia…
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a diabetes drug protect kidneys in polycystic disease? new trial aims to find out
Disease control Recruiting nowThis phase 3 trial tests whether the drug dapagliflozin can slow the loss of kidney function in adults with autosomal dominant polycystic kidney disease (ADPKD), a common genetic cause of kidney failure. The study will enroll 420 people aged 18 to 60 with rapid disease progressio…
Phase 3 • Sponsor: University of Cologne • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Keto diet tested as a way to delay kidney failure
Disease control Recruiting nowThis study looks at whether a well-formulated ketogenic diet can delay the progression of polycystic kidney disease in 20 adults who are at high risk for kidney failure. Participants will follow the diet for one year and have regular blood tests, urine tests, and MRI scans to tra…
Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a keto diet help slow kidney disease? new study seeks answers
Disease control Recruiting nowThis study tests a 16-week nutritionist-led ketogenic diet program (Ren-Nu) with a medical food called KetoCitra in 20 adults with autosomal dominant polycystic kidney disease (ADPKD). The goal is to see if the diet can improve kidney function and other health markers while monit…
Sponsor: Richard Fatica • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New registry aims to unlock secrets of rare Kidney-Liver diseases
Knowledge-focused Recruiting nowThis study is creating a central database and tissue bank for rare diseases affecting the kidneys and liver, such as ARPKD and Joubert syndrome. Researchers will collect medical information, genetic samples, and tissues from 200 participants to help doctors and scientists better …
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Kidney disease drug under the microscope: how does tolvaptan really work?
Knowledge-focused Recruiting nowThis study is tracking up to 2,000 people with autosomal dominant polycystic kidney disease (ADPKD) who are taking or considering tolvaptan. Researchers will collect real-world data on dosing, side effects, and kidney function over time. The goal is to understand how the drug is …
Sponsor: University of Cologne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Scientists launch biobank to unlock secrets of early kidney disease
Knowledge-focused Recruiting nowThis observational study is collecting blood and urine samples from 250 people with early-stage polycystic kidney disease (PKD), their unaffected family members, and healthy volunteers. The goal is to create a biobank that researchers can use to find biological markers of disease…
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Massive PKD data collection aims to unlock secrets of kidney disease
Knowledge-focused Recruiting nowThis study is building a large database of health information from people with autosomal dominant polycystic kidney disease (PKD), the most common inherited kidney disease. Researchers will collect data from 1,000 adults over time to better understand complications like high bloo…
Sponsor: The Rogosin Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New registry aims to speed up PKD research
Knowledge-focused Recruiting nowThis study is creating a registry and biobank of 350 adults with autosomal dominant polycystic kidney disease (ADPKD) in the Mid-Atlantic region. Participants will provide medical information, have kidney volume measured by MRI, and donate blood, urine, and DNA samples. The goal …
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:39 UTC